4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-037588
CIK 0001356857operating
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:10 PM ET
Size
5.4 KB
Accession
0001209191-13-037588
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-07-22$12.10/sh−1,000$12,100→ 166,860 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 5:10 PM ET
- Size
- 5.4 KB